Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage

Cell Proliferation

Volumn 37, Issue 6, 2004, Pages 385-400

  Booth, C ^a,b   Booth, D ^a,b   Williamson, S ^a   Demchyshyn, L L ^c   Potten, Chris S ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b Epistem Ltd   (United Kingdom)

^c NPS Pharmaceuticals Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 2; RADIOPROTECTIVE AGENT; TEDUGLUTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION INJURY; RADIATION PROTECTION; SMALL INTESTINE MUCOSA; STEM CELL;

ANIMALS; BIOLOGICAL ASSAY; CELL SURVIVAL; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GAMMA RAYS; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; INTESTINE, SMALL; MALE; MICE; ORGAN SIZE; PEPTIDES; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; STEM CELLS;

ANIMALIA; MURINAE;

EID: 9644257110     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2004.00320.x     Document Type: Article

References (46)

1. BENJAMIN MA, MCKAY DM, YANG PC, CAMERON H, PERDUE MH (2000) Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47, 112.
2. BJERKNES M, CHENG H (2001) Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc. Natl Acad. Sci. USA 98, 12497.
3. BLOOM SR (1972) An enteroglucagon tumour in man. Gut 13, 520.
4. BOOTH D, HALEY JD, BRUSKIN AM, POTTEN CS (2000) Transforming growth factor β3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem cell cycling. Int. J. Cancer 86, 53.
5. BOUSHEY R., YUSTA B, DRUCKER DJ (1999) Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am. J. Physiol. 211, E937.
6. BOUSHEY RP, YUSTA B, DRUCKER DJ (2001) Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res. 61, 687.
7. BRISTOL JB, WILLIAMSON RC (1988) Nutrition, operations, and intestinal adaptation. J. Parenter. Enteral. Nutr. 12, 299.
8. BURRIN DG, JIANG R., PETERSEN Y, ELNIF J, BUDDINGTON RK, SCHMIDT M, HOLST JJ, HARTMANN B, SAMGILD PT (2000) GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G1249.
9. BYRNE MM, MCGREGOR GP, BARTH P, ROTHMUND M, GOKE B, ARNOLD R. (2001) Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1, GLP-2 and PYY-producing neuroendocrine carcinoma. Digestion 63, 61.
10. CAMERON HL, YANG PC, PERDUE MH (2003) Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G905.
11. CHANCE WT, FOLEY-NELSON T, THOMAS I, BALASUBRAMANIAM A (1997) Prevention of parenteral nutrition-induced gut hypoplasia by co-infusion of glucagon-like peptide-2. Am. J. Physiol. 273, G559.
12. CHANCE WT, SHERIFF S, FOLEY-NELSON T, THOMAS I, BALASUBRAMANIAM A (2000) Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2. Nutr. Cancer 37, 215.
13. DRUCKER DJ, EHRLICH P, ASA SL, BRUBAKER PL (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl Acad. Sci. USA 93, 7911.
14. 2] glucagon-like peptide 2. Am. J. Physiol. 273, G1252.
15. DRUCKER DJ, YUSTA B, BOUSHEY RP, DEFOREST L, BRUBAKER PL (1999) Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am. J. Physiol. 276, G79.
16. DU XX, DOERSCHUK CM, ORAZI A, WILLIAMS DA (1994) A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83, 33.
17. FARRELL CL, BREADY JV, REX KL, CHEN JN, DIPALMA CR, WHITCOMB KL, YIN S, HILL DC, WIEMANN B, STARNES CO, HAVILL AM, LU ZN, AUKERMAN SL, PIERCE GF, THOMASON A, POTTEN CS, ULICH TR, LACEY DL (1998) Keratinocyte growth factor protects mice from chemotherapy- and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58, 933.
18. GLEESON MH, BLOOM SR, POLAK JM, HENRY K, DOWLING RH (1971) Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 12, 773.
19. LITVAK DA, HELLMICH MR, EVERS BM, BANKER NA, TOWNSEND CM JR. (1998) Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J. Gastrointest. Surg. 2, 146.
20. MARSHMAN E, BOOTH C, POTTEN CS (2002) The intestinal epithelial stem cell. Bioessays 24, 91.
21. MUNROE DG, GUPTA AK, KOOSHESH F, VYAS TB, RIZKALLA G, WANG H, DEMCHYSHYN L, YANG ZJ, KAMBOJ RK, CHEN H, MCCALLUM K, SUMNER-SMITH M, DRUCKER DJ, CRIVICI A (1999) Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl Acad. Sci. USA 96, 1569.
22. ORAZI A, DU X, YANG Z, KASHAI M, WILLIAMS DA (1996) Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Invest. 75, 33.
23. PARIS F, FUKS Z, KANG A, CAPODIECI P, JUAN G, EHLEITER D, HAIMOVITZ-FRIEDMAN A, CORDON-CARDO C, KOLESNICK R. (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293.
24. POTTEN CS (1995) Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int. J. Cancer. 62, 356.
25. POTTEN CS (1996) Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 14, 452.
26. POTTEN CS (1998) Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353, 821.
27. POTTEN CS (2004) Radiation the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Rad. Res. 161, 123.
28. POTTEN CS, HENDRY JH (1985) The microcolony assay in mouse small intestine. In: Potten CS, Hendry JH, eds. Cell Clones: Manual of Mammalian Cell Techniques, pp. 155. Edinburgh: Churchill Livingstone.
29. POTTEN CS, REZVANI M, HENDRY JH, MOORE JV, MAJOR D (1981) The correction of intestinal microcolony counts for variation in size. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 40, 321.
30. POTTEN CS, OWEN G, ROBERTS SA (1990) The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int. J. Rad. Biol. 57, 185.
31. POTTEN CS, OWEN G, HEWITT D, CHADWICK CA, HENDRY JH, LORD BI, WOOLFORD LB (1995) Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration in growth factors. Gut 36, 864.
32. POTTEN CS, BOOTH D, HALEY JD (1997a) Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo. Br. J. Cancer 75, 1454.
33. POTTEN CS, BOOTH C, PRITCHARD DM (1997b) The intestinal epithelial stem cell: the mucosal governor. Int. J. Exp. Pathol. 78, 219.
34. POTTEN CS, O'SHEA J, FARRELL CL, REX K, BOOTH C (2001) The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine. Cell Growth Diff. 12, 265.
35. POTTEN CS, BOOTH D, CRAGG NJ, TUDOR GL, O'SHEA JA, APPLETON D, BARTHEL D, GERIKE TG, MEINEKE FA, LOEFFLER M, BOOTH C (2002a) Cell kinetic studies in the murine ventral tongue epithelium: thymidine metabolism studies and circadian rhythm determination. Cell Prolif. Suppl. 35, 1.
36. POTTEN CS, BOOTH D, CRAGG NJ, TUDOR GL, O'SHEA JA, BOOTH C, MEINEKE FA, BARTHEL D, LOEFFLER M (2002b) Cell kinetic studies in the murine ventral tongue epithelium: mucositis induced by radiation and its protection by pre-treatment with keratinocyte growth factor (KGF). Cell Prolif. Suppl. 35, 32.
37. PRITCHARD DM, POTTEN CS, HICKMAN JA (1998) The relationships between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res. 58, 5453.
38. ROBERTS SA (1990) DRFIT: a program for fitting radiation survival models. Int. J. Radiat. Biol. 57, 1243.
39. ROMAND M, POLK WH, AWAD JA, ARTEAGA CL, NANNEY LB, WARGOVICH MJ, KRAUS ER, BOLAND CR, COFFEY RJ (1992) Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo. J. Clin. Invest. 90, 2409.
40. SCOTT RB, KIRK D, MACNAUGHTON WK, MEDDINGS JB (1998) GLP-2 augments the adaptive response to massive intestinal resection in rat. Am. J. Physiol. 275, G911.
41. STEVENS FM, FLANAGAN RW, O'GORMAN D, BUCHANAN KD (1984) Glucagonoma syndrome demonstrating giant duodenal villi. Gut 25, 784.
42. TSAI CH, HILL M, DRUCKER DJ (1997a) Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am. J. Physiol. 272, G662.
43. TSAI CH, HILL M, ASA SL, BRUBAKER PL, DRUCKER DJ (1997b) Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am. J. Physiol. 273, E77.
44. WITHERS HR, ELKIND MM (1970) Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol. Stud. Phys. Chem. Med. 17, 261.
45. XIAO Q, BOUSHEY RP, DRUCKER DJ, BRUBAKER PL (1999) Secretion of the intestinotrophic hormone glucgon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117, 99.
46. ZEEH JM, PROCACCINO F, HOFFMANN P, AUKERMAN SL, MCROBERTS JA, SOLTANI S, PIERCE GF, LAKSHMANAN J, LACEY D, EYSSELEIN VE (1996) Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110, 1077.